Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP).
Rizzo M, Colletti A, Penson PE, Katsiki N, Mikhailidis DP, Toth PP, Gouni-Berthold I, Mancini J, Marais D, Moriarty P, Ruscica M, Sahebkar A, Vinereanu D, Cicero AFG, Banach M; International Lipid Expert Panel (ILEP). Rizzo M, et al. Pharmacol Res. 2023 Mar;189:106679. doi: 10.1016/j.phrs.2023.106679. Epub 2023 Feb 8. Pharmacol Res. 2023. PMID: 36764041 Free article. Review.
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
Penson PE, Bruckert E, Marais D, Reiner Ž, Pirro M, Sahebkar A, Bajraktari G, Mirrakhimov E, Rizzo M, Mikhailidis DP, Sachinidis A, Gaita D, Latkovskis G, Mazidi M, Toth PP, Pella D, Alnouri F, Postadzhiyan A, Yeh HI, Mancini GBJ, von Haehling S, Banach M; International Lipid Expert Panel (ILEP). Penson PE, et al. Among authors: rizzo m. J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1596-1622. doi: 10.1002/jcsm.12960. Epub 2022 Mar 10. J Cachexia Sarcopenia Muscle. 2022. PMID: 35969116 Free PMC article. Review.
Effects of Trehalose Administration in Patients with Mucopolysaccharidosis Type III.
Mobini M, Radbakhsh S, Kubaski F, Eshraghi P, Vakili S, Vakili R, Abbasifard M, Jamialahmadi T, Rajabi O, Emami SA, Tayarani-Najaran Z, Rizzo M, Eid AH, Banach M, Sahebkar A. Mobini M, et al. Among authors: rizzo m. Curr Med Chem. 2023 Apr 6. doi: 10.2174/0929867330666230406102555. Online ahead of print. Curr Med Chem. 2023. PMID: 37038706
Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials.
Patoulias D, Popovic DS, Stoian AP, Janez A, Sahebkar A, Rizzo M. Patoulias D, et al. Among authors: rizzo m. J Diabetes Complications. 2023 Aug;37(8):108529. doi: 10.1016/j.jdiacomp.2023.108529. Epub 2023 Jun 7. J Diabetes Complications. 2023. PMID: 37301063 Review.
2,302 results